Romana Jarosova, Ph.D. Abstract Chemotherapy-induced cognitive impairment (CICI), commonly referred to as chemobrain or chemofog, is an increasingly recognized adverse effect of cancer chemotherapy. Characterized by deficits in memory, attention, and executive function, chemobrain affects up to 75% of patients during treatment, with many survivors continuing to experience cognitive symptoms...